Agios Appoints Richa Poddar as Chief Commercial Officer
CAMBRIDGE, Mass., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the field of cellular metabolism to treat genetically defined diseases, today announced the appointment of Richa Poddar to the role of chief commercial officer, effective Dec. 6, 2021.
- CAMBRIDGE, Mass., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the field of cellular metabolism to treat genetically defined diseases, today announced the appointment of Richa Poddar to the role of chief commercial officer, effective Dec. 6, 2021.
- Ms. Poddar will replace Darrin Miles, who currently serves as the companys chief commercial officer and has been with Agios since 2015.
- Miles will depart the company to pursue a chief executive officer role at a private biotechnology company.
- I look forward to more great things from her as our new chief commercial officer.